APR 27, 2017 2:41 PM PDT

Cheap Drug Drastically Cuts Maternal Deaths

WRITTEN BY: Xuan Pham

A drug created created in the 1960s is now credited as a powerful tool that can save thousands of women from bleeding to death during and after childbirth.

In an international trial that included 20,000 women in 21 countries, researchers found that the drug called tranexamic acid drastically reduced the risks of women dying from postpartum hemorrhage. The condition of heavy bleeding after childbirth affects 100,000 women every year, making it the biggest cause of maternal death worldwide.

Tranexamic stops heavy bleeding by inhibiting the breakdown of blood clots. The drug slashed deaths related to hemorrhaging by 31 percent in women given the drug within three hours of childbirth.

In addition to its impressive effectiveness, researchers are also praising the drug’s cheap cost and minimal side effects. The drug is estimated to cost $3 in the UK, and even less in other countries, such as Pakistan.

"We found an inexpensive drug, given in a single shot, that reduces the risk of bleeding to death, and it should play a role in reducing maternal mortality around the world,” said Ian Roberts, one of the researchers.

"If you can save a life for approximately $3, then I believe that's worth doing," added Haleema Shakur, who directs clinical trials at the London School of Tropical Medicine and Hygiene.

Interestingly enough, the drug that’s now being lauded as a game-changer for preventing childbirth deaths was nearly all but forgotten since it was invented in the 1960s by a Japanese husband-wife pair, Shosuke and Utako Okamoto. According to Shakur, "It was Okamoto's dream to save women. But she couldn't convince doctors to test the drug on postpartum hemorrhaging."

Instead, the drug was marketed as treatment for heavy periods. If it wasn’t for the efforts of Shakur and colleagues, the drug may not have been resurrected for such a powerful purpose.

For Ukato Okamoto, it is never too late to save lives. "We wanted to work on something international, we wanted to discover new drugs to show our gratitude to humanity," she said of her and her husband’s goals decades ago. "We thought that would be wonderful."

Additional sources: BBC

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 26, 2020
Clinical & Molecular DX
Nanoengineering Aids Bladder Cancer Detection
MAY 26, 2020
Nanoengineering Aids Bladder Cancer Detection
   
JUL 07, 2020
Cardiology
Investigating New Ways to Diagnose a Heart of Bone
JUL 07, 2020
Investigating New Ways to Diagnose a Heart of Bone
Calcific aortic stenosis, or calcific aortic valve disease (CAVD), is a progressive cardiovascular disease where the aor ...
JUL 14, 2020
Clinical & Molecular DX
The Smell of Rotten Fish Could Help Predict the Recovery of Unresponsive Patients
JUL 14, 2020
The Smell of Rotten Fish Could Help Predict the Recovery of Unresponsive Patients
A study published in the journal Nature provides new evidence supporting an unconventional test to map recovery paths of ...
SEP 02, 2020
Cancer
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
SEP 02, 2020
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
For many rare diseases, there is a lack of a “standard” treatment options. This is more prevalent in diverse ...
SEP 01, 2020
Clinical & Molecular DX
Scalp Implants Monitor Epileptic Seizures
SEP 01, 2020
Scalp Implants Monitor Epileptic Seizures
Neuroscientists have developed devices that, when implanted under the scalp of individuals living with epilepsy, can mon ...
SEP 14, 2020
Health & Medicine
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
SEP 14, 2020
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
As the SARS-CoV-2 pandemic continues to rage across the United States and around the globe, the demand for COVID-19 test ...
Loading Comments...